Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a ph...

por Pavelka, Karel, Szekanecz, Zoltán, Damjanov, Nemanja, Anić, Branimir, Tomšič, Matija, Mazurov, Vadim, Maksimovic, Marija, Nagy, Orsolya, Świerkot, Jerzy, Petranova, Tzvetanka, Veldi, Tiina, Baranauskaitė, Asta, Codreanu, Catalin, Andersone, Daina, Fleischmann, Roy
Publicado 2020

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

por Orlewska, Ewa, Ancuta, Ioan, Anic, Branimir, Codrenau, Catalin, Damjanov, Nemanja, Djukic, Predrag, Ionescu, Ruxandra, Marinchev, Lubomir, Nasonov, Evgeny L., Peets, Tonu, Praprotnik, Sonja, Rashkov, Rasho, Skoupa, Jana, Tlustochowicz, Witold, Tlustochowicz, Malgorzata, Tomsic, Matija, Veldi, Tiina, Vojinovic, Jelena, Wiland, Piotr
Publicado 2011